Re: Today's announcement of early earnings release matches the timing for last year's 2nd quarter release in 2016
You should stop posting on twitter. No one there engages in meaningful dialogue, so why bother?
I think the FDA later relented on the placebo being exon51 kids and changed it to other exons. Kaye mentioned that somewhere.
By the end of that trial the exon51 PPMO will probably have supplanted this original PMO so the trial will probably peter out anyway.
The primary endpoint is North Star not 6 minute walk test.
Do you think they'll release the exon53 data at the Rome conference? Is it July 19th too?